Skip to content
Abierto

Award notice, first published as presolicitation

Anti CD20 Antibodies

36E79724R0006

Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.

Awarded

TG Therapeutics Inc.

$0.00 obligated so far on USAspending

Description

As published on SAM.gov with the solicitation of February 5, 2024.

Extend Closing Date Effective 2/5/2024 This amendment is being issued to extend the closing date for solicitation 36E79724R0006 for Anti-CD20 Antibodies. The solicitation due date has been extended to February 20, 2024 and all offers are due by 2:30PM Central Time.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
JKPZKD19WMD7
CAGE
8TBE4
Vendor location
Edison, NJ
Contract
36E79724D0024
Obligated
$0.00, potential $186,776,520
Actions
8 between April 17, 2024 and September 2, 2026
Competition
Full and Open Competition, 4 offers received
Set-aside reported
No Set Aside Used.
Described as
New Award for Ublituximab-Xiiy 150mg/6ml Injection (Anti-Cd20 Antibodies with TG Therapeutics. Period of Performance June 17, 2024 - June 16, 2025 with Four ONE-YEAR Options.
Match
award number 36E79724D0024 equals the contract number; same awarding office 36E797 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. January 19, 2024

    Presolicitation

    Anti CD20 Antibodies (VA-24-00025874)

    Due February 26, 2024 at 3:30 PM EST. SAM.gov, notice 57a3cc4023814b9683b0e7039900b59d

  2. January 25, 2024

    Solicitation, originally presolicitation

    Anti CD20 Antibodies (VA-24-00025874)

    Due February 8, 2024 at 3:30 PM EST. SAM.gov, notice 76e43e096c6d4225892d217699c4a091

  3. January 26, 2024

    Solicitation

    Anti CD20 Antibodies (VA-24-00025874)

    Due February 19, 2024 at 3:30 PM EST. SAM.gov, notice 110a98ef99394970ac51e79c26f5afc7

  4. January 29, 2024

    Solicitation

    Anti CD20 Antibodies (VA-24-00025874)

    Due February 19, 2024 at 3:30 PM EST. SAM.gov, notice 7a2edcb9d3ee46f8bffe1b4b0b15f2c1

  5. February 5, 2024

    Solicitation

    Anti CD20 Antibodies (VA-24-00025874)

    Due February 20, 2024 at 3:30 PM EST. SAM.gov, notice 43d5425c05c443da843675da8af7a720

  6. April 17, 2024

    Award notice

    Awarded to TG Therapeutics Inc. Edison 08837 Jib for $186,776,520. SAM.gov, notice 5efea17b278941f7ae9ba627116a29be

Points of contact